Physician profile
Michael L Mason
NPI 1982686564
$745.77
in general payments reported to CMS, 2019-2025
6 companies · $320 in 2025
The $320 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.97 · 2020: $52.48 · 2021: $88.26 · 2022: $43.65 · 2023: $141 · 2024: $82.69 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $514 · Entertainment: $29.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $513.74 |
| Entertainment | $29.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $423.42 | 2019-2025 | Total30, Precision7, Precision 1 |
| Rxsight INC | $150.00 | 2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Sun Pharmaceutical Industries INC. | $80.44 | 2021-2023 | Cequa |
| Johnson & Johnson Surgical Vision, INC. | $38.36 | 2020 | |
| Optos, INC. | $29.67 | 2024-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $23.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.